Dr. Jeffrey Chamberlain is a member of the scientific advisory board for Solid.
Professor, Department of Neurology. Professor, Department of Biochemistry. Professor of Medicine, Division of Medical Genetics University of Washington
Dr. Jeffrey Chamberlain is a professor in the Departments of Neurology, Medicine and Biochemistry a the University of Washington, the McCaw Endowed Chair in Muscular Dystrophy at the University of Washington School of Medicine, and Director of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center of Seattle. The main focus of his research is on muscular dystrophies with two major goals: to develop a better understanding of the molecular basis of the pathophysiology of the diseases and to develop gene and cell therapies that will correct and treat the muscular dystrophies. Major targets for therapy include Duchenne muscular dystrophy and LGMD2I.
Currently, his laboratory includes ~15 scientists conducting cutting edge studies that may translate into clinical trials in the near future. He is working with some of the best doctors and scientists at Children’s Hospital, Fred Hutchinson Cancer Research Center, University of Rochester, and Harborview Medical Center to most effectively tackle the challenge ahead: to find a treatment for muscular dystrophy.